Physician profile
Randy Wei
NPI 1790045714
$8,953.91
in general payments reported to CMS, 2019-2025
19 companies · $3,183 in 2025
The $3,183 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,781 · 2020: $228 · 2021: $183 · 2022: $94.79 · 2023: $357 · 2024: $127 · 2025: $3,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,050 · Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,050.00 |
| Food and Beverage | $618.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $4,710.88 | 2019-2023 | Optune |
| Janssen Scientific Affairs, LLC | $2,440.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $610.00 | 2025 | |
| Brainlab, INC. | $303.42 | 2020-2023 | Image Guided Surgical Device |
| Siemens Medical Solutions USA, INC. | $144.65 | 2022-2024 | Varian Ethos Treatment Planning, Bravos Afterloader System |
| Bayer Healthcare Pharmaceuticals INC. | $140.92 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $116.45 | 2021 | |
| Teleflex LLC | $102.47 | 2025 | Barrigel |
| Tempus Ai, INC | $87.60 | 2024 | Xt Cdx |
| Telix Pharmaceuticals | $56.38 | 2023-2025 | Illuccix |
| Lilly USA, LLC | $50.60 | 2019 | |
| Palette Life Sciences, INC. | $43.23 | 2022 | |
| Tactile Systems Technology INC | $42.78 | 2019-2021 | |
| Ambu INC. | $33.81 | 2021 | |
| Curium US LLC | $24.00 | 2023 | Detectnet |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.72 | 2021 | |
| Fortovia Therapeutics, INC. | $14.01 | 2019 | |
| Accuray Incorporated | $13.99 | 2023 | Tomo Therapy System, Cyberknife System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.